Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
217.68
-6.43 (-2.87%)
Jun 1, 2026, 3:52 PM EDT - Market open
Ascendis Pharma Market Cap
Ascendis Pharma has a market cap or net worth of $13.52 billion as of June 1, 2026.
Market Cap
13.52B
Enterprise Value
14.05B
1-Year Change
n/a
Ranking
Category
Stock Price
$217.68
Market Cap Chart
Since April 20, 2026, Ascendis Pharma's market cap has decreased from $15.16B to $13.52B, a decrease of -10.81%. That is a compound annual growth rate of -65.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 13.92B | -5.63% |
| May 28, 2026 | 14.75B | 0.94% |
| May 27, 2026 | 14.61B | -1.83% |
| May 26, 2026 | 14.89B | -3.00% |
| May 22, 2026 | 15.34B | -0.19% |
| May 21, 2026 | 15.37B | 2.56% |
| May 20, 2026 | 14.99B | 1.41% |
| May 19, 2026 | 14.78B | 0.14% |
| May 18, 2026 | 14.76B | -1.19% |
| May 15, 2026 | 14.94B | -2.03% |
| May 14, 2026 | 15.25B | 0.78% |
| May 13, 2026 | 15.13B | 2.50% |
| May 12, 2026 | 14.76B | -0.43% |
| May 11, 2026 | 14.82B | - |
| May 8, 2026 | 14.82B | -3.04% |
| May 7, 2026 | 15.29B | 4.90% |
| May 6, 2026 | 14.57B | 4.71% |
| May 5, 2026 | 13.92B | -1.50% |
| May 4, 2026 | 14.13B | 3.52% |
| May 1, 2026 | 13.65B | -3.68% |
| Apr 30, 2026 | 14.17B | 4.13% |
| Apr 29, 2026 | 13.61B | -0.81% |
| Apr 28, 2026 | 13.72B | -2.02% |
| Apr 27, 2026 | 14.00B | -1.14% |
| Apr 24, 2026 | 14.16B | 1.90% |
| Apr 23, 2026 | 13.90B | -2.62% |
| Apr 22, 2026 | 14.27B | -3.85% |
| Apr 21, 2026 | 14.85B | -2.07% |
| Apr 20, 2026 | 15.16B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genmab | 16.34B |
| Jazz Pharmaceuticals | 14.84B |
| Summit Therapeutics | 13.61B |
| BridgeBio Pharma | 12.98B |
| Exelixis | 12.69B |
| Ionis Pharmaceuticals | 12.64B |
| Axsome Therapeutics | 12.07B |
| Madrigal Pharmaceuticals | 11.46B |